One of our key objectives is to provide consumers quality, effective and safe medicines, which benefits exceed the potential risks.

In order to ensure control of safety and effectiveness of medicines, pharmacovigilance system is functioning at the enterprise in accordance with the requirements of current legislation, international standards and ethical principles of the company.

Pharmacovigilance process begins at the stage of drug development and continues throughout its life cycle.

Timely detection of adverse reactions and reporting to regulatory authorities allows their analysis and on the basis of its results to develop and introduce into practice measures aimed at preventing adverse consequences of drug therapy, enhancing its safety, consequently, the quality of life of patients, continually assess the balance in which the benefits from the use of our medicines outweigh the possible risks.

The message should contain the following minimum of information:

  • the name of the suspected drug;
  • description of adverse reactions and / or indications of lack of efficacy;
  • information about the patient, in whom occurred adverse reaction (name / initials, age, sex, and other important information);
  • contact information and information about the person that sends a message (the doctor, the patient, a relative or a patient representative).

If you want to report the occurrence of adverse reactions and / or lack of efficacy in the medical use of pharmaceuticals produced in our company, please contact the Department of Pharmacovigilance in convenient way for you:

You can download and fill out the form provided (Individual safety case report):

Individual safety case report

Provide by telephone, fax or e-mail.

Address: Khlebozavodskaya str., 2, Ladyzhyn, Vinnitsa region, 24321, Ukraine
Phone: (round-the-clock autoanswer): +38 068 340 15 72
Факс: +38 0432 555 621

All the information you provide is confidential and shall not be disclosed except as required by law.

Our partners

Our clients